Received Apr 10, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEP | HEP B (HEPLISAV-B) | DYNAVAX TECHNOLOGIES CORPORATION | 1 | 945657 | IM / RA |
Employee reported to be symptomatic at 1900 with symptoms of increase heart rate (105BPM) and nausea. No treatment due to symptoms decreasing after sitting and drinking water. Symptoms resolved at 1942.
N/A
N/A
N/A
N/A
N/A